Levofloxacin alleviates blood-brain barrier disruption following cerebral ischemia and reperfusion via directly inhibiting A-FABP.
Yang S, Xu D, Zhang D, Huang X, Li S, Wang Y, Lu J, Wang D, Guo ZN, Yang Y, Ye D, Wang Y, Xu A, Hoo RLC, Chang J.
Yang S, et al. Among authors: xu a, xu d.
Eur J Pharmacol. 2024 Jan 15;963:176275. doi: 10.1016/j.ejphar.2023.176275. Epub 2023 Dec 17.
Eur J Pharmacol. 2024.
PMID: 38113968